Parkinson Disease

Recent research describes the cascade of neuronal death and the spread of abnormal protein aggregates throughout the brain in Parkinson disease.

Marijuana is not legal in Norway, where a survey of patients with Parkinson disease (PD) found a little more than 11% were current or former consumers of cannabis.

Vitamin D is thought to have neuroprotective effects and it is usually lacking in patients with Parkinson disease (PD).

The findings about this inverse relationship were based on national health registries in Denmark.

Researchers sought to discover if a study specific to China would show similar patterns in health-related quality of life (HRQOL) between male and female patients with Parkinson disease (PD).

The researchers said they did the study with the aim of finding more information about the interaction between age and Parkinson disease (PD) in an effort to improve patient management and therapy development.

Researchers think they know more about why levodopa, the first-line therapy for treating the motor symptoms of Parkinson disease (PD), loses efficacy and causes dyskinesia, or off periods, the longer a patient stays on it.

A recently published meta-analysis examined the extent to which cognitive rehabilitation is useful in Parkinson disease (PD), since other reports on the matter have been mixed.

Safinamide belongs to a class of drugs called monoamine oxidase type B inhibitors and is used in conjunction with levodopa to manage OFF periods.

People with Parkinson disease who regularly consumed flavonoids like berries, red wine, tea, and apples had lower rates of death than people who didn’t, according to a new study.

Researchers said they wanted to take a broad look at the level and scope of the disruption for those with Parkinson disease and dementia still living at home and compare the findings to before the pandemic.

Researchers wanted to understand more about the impact of medication management and other quality-of-life issues related to this neurological disease on both patients and caregivers.

Older patients with Parkinson disease (PD) were found to have a higher incidence of dementia compared with younger patients. However, the difference may have to do with different pathologies causing dementia in older and younger patients.

A recent review suggests that some genes may influence the severity of cognition impairment in Parkinson disease.

A case-control study from Denmark suggests that having influenza may increase the risk of Parkinson disease more than a decade later.

Researchers sought to examine the effect on corresponding regions of the brain after patients with Parkinson disease (PD) and swallowing problems underwent functional magnetic resonance imaging (fMRI) after receiving 10 sessions of repetitive transcranial magnetic stimulation.

The top 5 most-read Parkinson disease articles of 2021 explored some of the new tactics being used to manage the disease, such as herbal tea, acupuncture, wearable tech, and cannabis.

A new study comparing intensive care unit stays among patients with Parkinson disease and controls without the disease found the former have more severe illness, but both groups have similar survival rates.

Until now, researchers have not quantified the impact of regular exercise on death for any reason in patients with Parkinson disease (PD).

The preliminary analysis, appearing in a preprint journal, looked at lifestyle habits of those with Parkinson disease.

Researchers at the University of Rochester are analyzing facial muscle movements through videos taken over webcams or smartphones to train a machine learning algorithm with the hope that it can predict Parkinson disease at an earlier stage.

Mild cognitive impairment has been proposed as a marker for the prodromal phase of Parkinson disease (PD), but little is known about its presentation in community-dwelling older adults.

The meta-analysis sought to clarify previous research, which has explored the idea that Parkinson disease (PD) is tied to inflammation in the gastrointestinal tract, noting that inflammatory bowel disease (IBD) has been implicated in neuroinflammation.

Treatment strategies focused on dopaminergic regeneration rather than symptomatic relief may transform the way Parkinson disease is managed.

The guideline reflects findings regarding confidence in evidence about how to care for the motor symptoms in patients with early Parkinson disease (PD), including the comparative efficacy of treatments as well as the comparative risk of adverse events.

An overview of the latest clinical news in Parkinson disease reported across MJH Life Sciences™.

Recent research from the United Kingdom sought to understand more about factors that may impact the location of death for patients with Parkinson disease (PD) and multiple sclerosis (MS).

In this new study, researchers examined 50 patients with PD, including 22 with sleep apnea and 28 without; patients were examined both before and after deep brain stimulation.

Researchers found that the degree to which a person with idiopathic Parkinson disease engages in these avoidance tactics—such as putting a hand in the pocket to hide a tremor—is moderately predictive of social anxiety. The trouble is, such strategies may make anxiety worse, and patients can develop social anxiety disorder.

Responses from the Fox Insight study describe how patients with Parkinson disease experience OFF periods as expressed in both motor and nonmotor symptoms.